Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Naveen Kumar

University Hospital of Bern

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · JOURNAL ARTICLE

FAP-Inhibitor Homodimers with Engineered Linker-SpacerUnits: Toward Optimized Radiopharmaceuticals

Acs Omega

This is preclinical chemical and radiochemical characterization of novel compounds with in vitro binding and cell studies, lacking in vivo efficacy data or clinical translation to support therapeutic claims.

PreliminaryEleni Gourni Naveen Kumar Marcel Martin

Reported

FAP affinity (Kd)1.1–1.2 nM

Cell internalization at 30 minutesup to 95%

Radiochemical purityhigh to quantitative

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support